Xiretsa wins Stage II Funding: boosting a new class of Antibiotics
February 2024 – Xiretsa, Inc is the second selected venture [...]
SPRIND calls for unconventional innovations to fight AMR
Do you have an outstanding antimicrobial resistance (AMR) innovation that [...]
The finalists for the Start-up Pitch Event have been chosen!
After receiving over 40 applications and going through a rigorous [...]
Look back on 2023
As December arrives and 2023 draws to a close, it's [...]
INCATE and Kineticos join forces in supporting AMR innovators
December 6th 2023 – INCATE (the INCubator for Antibacterial Therapies [...]
STAGE I October 2023 selection
The INCATE Selection Committee selected the last 4 new ventures [...]
“Creative Funding” webinar recording and presentations
On November 8th 2023 we organized INCATEs 3rd Entrepreneurs Club [...]
PACE, the new £30m Initiative to Address Global Threat by Accelerating the Pace of Antimicrobial Innovation
Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined [...]
INCATE and BIOASTER join forces to improve support to AMR innovators
November 1st, 2023 - INCATE (the INCubator for Antibacterial Therapies [...]
Entrepreneurs Club #3: “Creative Funding – getting non-dilutive funding for your AMR Project”
The Entrepreneurs Club is back! Join this 3rd INCATE Entrepreneurs [...]
